Docosahexaenoic Acid (DHA) for the Improvement of Neurodevelopmental Outcome in Preterm Infants -The DINO trial

Dataset

Description

This dataset includes infants born < or = 32 weeks gestation that were given breast milk from mothers whose diet was supplemented with tuna oil capsules 6x 500mg DHA rich tuna oil capsules per day to increase DHA in breast milk. The intervention commenced within 5 days of the preterm infant commencing enteral feeds and continued until the expected term date (40 weeks post menstrual age). Growth was measured at 4, 12 and 18 months corrected age. The primary outcome for the follow-up study was general intellectual ability (Full Scale IQ) as estimated with the Wechsler Abbreviated Scale of Intelligence (WASI) at seven years' corrected age.
Date made available2023
PublisherSouth Australian Health and Medical Research Institute
Temporal coverage4 Apr 2001 - 10 Jul 2013
Date of data production2023
Geographical coverageSouth Australia Victoria Queensland Western Australia

Cite this